OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?

HTML

Year: 2010
Type: review
Source: Drugs
DOI: 10.2165/11536100-000000000-00000
Authors: Jon O. Ebbert, J. Taylor Hays, Richard D. Hurt
Institution: Mayo Clinic
Language: English

Topic: Smoking Behavior and Cessation
Subfield: Public Health, Environmental and Occupational Health
Field: Medicine
Domain: Health Sciences
Keywords: smoking cessation, combination pharmacotherapy, nicotine replacement therapy, bupropion, tobacco dependence, nicotine abstinence, monotherapy, cost-effectiveness, drug synergy
SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, National Institutes of Health, U.S. Public Health Service, National Cancer Institute
Awards: G1608779987, Combination Therapy with Varenicline and Bupropion for Smoking Cessation
OpenAlex ID: W2080075236
FWCI: 0.544
Cites: 43
Cited by: 57
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security